Cargando…
Guanxinkang Decoction Attenuates the Inflammation in Atherosclerosis by Regulating Efferocytosis and MAPKs Signaling Pathway in LDLR(−/−) Mice and RAW264.7 Cells
Guanxinkang decoction (GXK), a traditional Chinese medicinal drug, is used to treat cardiovascular disease. The aim of the study was to investigate the effects of GXK on inflammation in LDLR(−/−) mice and RAW264.7 cells. Fed with high fat diet for 12 weeks, the mice were randomly divided into six gr...
Autores principales: | Zhang, Yifan, Ding, Jie, Wang, Yiru, Feng, Xiaoteng, Du, Min, Liu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688952/ https://www.ncbi.nlm.nih.gov/pubmed/34950025 http://dx.doi.org/10.3389/fphar.2021.731769 |
Ejemplares similares
-
Tanshinone IIA alleviates atherosclerosis in LDLR(−/−) mice by regulating efferocytosis of macrophages
por: Wang, Jiarou, et al.
Publicado: (2023) -
Salvianolic acid B attenuates the inflammatory response in atherosclerosis by
regulating MAPKs/ NF-κB signaling pathways in LDLR-/- mice and RAW264.7
cells
por: Zhang, Yifan, et al.
Publicado: (2022) -
Taoren Honghua Drug Attenuates Atherosclerosis and Plays an Anti-Inflammatory Role in ApoE Knock-Out Mice and RAW264.7 Cells
por: Wang, Yiru, et al.
Publicado: (2020) -
Monascin abrogates RANKL-mediated osteoclastogenesis in RAW264.7 cells via regulating MAPKs signaling pathways
por: Cheng, Yin, et al.
Publicado: (2022) -
Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity
por: Deng, Wei, et al.
Publicado: (2022)